CAROTUXIMAB

UNII:	YB2EWE6139
Formula:
Preferred Substance Name:	CAROTUXIMAB

1268714-50-6
CAROTUXIMAB [INN]
CAROTUXIMAB [USAN]
CAROTUXIMAB [WHO-DD]
C-SN6J
DE-122
GAMMA1 HEAVY CHAIN (1-448) (MUS MUSCULUS VH (IGHV6-6*01-(IGHD) -IGHJ2*01) (8.10.9) (1-118) -HOMO SAPIENSIGHG1*01, GM17,1 (CH1 (119-216), HINGE (217-231), CH2(232-341), CH3 (342-446), CHS (447-448)) (119-448)), (221-213')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-213') (CHIMERIC VKAPPA(MUS MUSCULUS IGKV4-72*01 -HOMO SAPIENSIGKJ5*01) (5.3.9) (1'-106') -HOMO SAPIENS IGKC*01, KM3(107'-213')) DIMER (227-227'':230-230'')-BISDISULFIDE
IMMUNOGLOBULIN G1, ANTI-(HUMAN ENDOGLIN) (HUMAN-MUS MUSCULUS MONOCLONAL TRC105 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TRC105 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HUMAN ENDOGLIN (CD105 ANTIGEN)) HUMAN MOUSE CHIMERIC MONOCLONAL ANTIBODY .GAMMA.1 HEAVY CHAIN (1-448) (MOUSE VH (MUS MUSCULUS IGHV6-6*01 (98%) (IGHD)-IGHJ2*01 (87%)) (8.10.9) (1-118) -HOMO SAPIENS IGHG1*01 (119-448)) (221-213')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-213') (MOUSE V-KAPPA (MUS MUSCULUS IGKV4-72*01 (99%) IGKJ5*01) (5.3.9) (1'-106') -HOMO SAPIENS IGKC*01 (107'-213')), DIMER (227-227'':230-230'')-BISDISULFIDE
TRC105
TRC-105

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CAROTUXIMAB

Synonyms and Mappings

Resources